Skip to content

Author

Peter Alping

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Risk of Inflammatory Bowel Disease After Anti-CD20 Treatment in Multiple Sclerosis

This cohort study investigates if anti-CD20 treatment is associated with an increase in the risk of inflammatory bowel disease in individuals with multiple sclerosis (MS).

Sandra Kallin, A. Svenningsson, O. Olén et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.